The effectiveness of self-efficacy-based intervention on self-care level in diabetic adolescents
Phase 1
- Conditions
- Diabetes Mellitus.E10 Insulin-dependent diabetes mellitus, E11 Non-insulin-dependent diabetes mellitus, E12 Malnutrition-related diabetes mellitus, E13 Other specified diabetes mellitus, E14 Unspecified diabetes mellitusE10, E 11,
- Registration Number
- IRCT201201055499N2
- Lead Sponsor
- The Office of the Vice chancellor for research, Guilan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
age between 11 and 20 ; being single; diabetic diagnosis at least for past two months.
Exclusion criteria: having hemoglobinopathy, anemia, reticulocytosis and uremia during study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Self-care. Timepoint: Prior to the intervention,Immediately and after the intervention and after three months. Method of measurement: Diabetic adolescents self-care questionnaire.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link self-efficacy interventions to improved glycemic control in IRCT201201055499N2 diabetic adolescents?
How does self-efficacy-based intervention compare to standard diabetes education in E10/E11 adolescents' HbA1c outcomes?
Which biomarkers correlate with adherence to self-care regimens in IRCT201201055499N2 participants with insulin-dependent diabetes?
What adverse events are reported in phase I self-efficacy trials for E11 adolescents, and how are they managed?
Are there synergistic effects of combining self-efficacy programs with GLP-1 receptor agonists in IRCT201201055499N2 diabetes management?